Availability of Epirubicin

HPS Pharmacies wish to advise that Accord Healthcare is experiencing a supply interruption for epirubicin as follows:

Epirubicin Accord
Epirubicin hydrochloride 200mg/100mL
ARTG 227997

Normal supplies of Epirubicin Accord are expected to return by early September 2024. HPS Pharmacies also sources compounded epirubicin products from Baxter Healthcare. These products have been subject to a reduced shelf-life due to a supply shortage from their supplier. These compounded epirubicin products are due to expire on 31 May 2024.

Baxter Healthcare anticipates approval to supply an internationally registered epirubicin product shortly via Section 19A of the Therapeutic Goods Act 1989. The timing of this approval from the Therapeutic Goods Administration (TGA) may affect the availability of epirubicin doses due between 31 May 2024 and 4 June 2024. HPS Pharmacies will provide further details once they are available.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Accord Healthcare on 1800 222 673, or your pharmacist at HPS Pharmacies.

Download PDF